We overpaid for him it looks like so far. He isn't useless but isn't clinical enough to be a first choice CF and not pacey enough to be a first choice winger.
In a nutshell, it seems like we've paid for good squad depth rather than a key piece in the puzzle.
It's still very early doors though of course.